Basic Information
LncRNA/CircRNA Name | ENST00000462717 |
Synonyms | PSMD6-AS1, lnc00462717 |
Region | GRCh38_3:64011964-64016246 |
Ensemble | ENSG00000243410 |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | papillary thyroid cancer |
ICD-0-3 | NA |
Methods | Microarray, qPCR etc. |
Sample | blood |
Expression Pattern | up-regulated |
Function Description | Compared with 131I-avid lung metastases, we discovered that two lncRNAs (ENST00000462717 and ENST00000415582) were upregulated and two (TCONS_00024700 and NR_028494) were downregulated in the non-131I-avid lung metastases of PTC. Low (ENST00000462717 and ENST00000415582) and high plasma lncRNA levels (TCONS_00024700 and NR_028494) were also found to be associated with better prognosis of PTC patients with lung metastases. |
Pubmed ID | 27997908 |
Year | 2016 |
Title | Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting 131I Uptake and Mortality in Papillary Thyroid Cancer Patients with Lung Metastases. |
External Links
Links for ENST00000462717 | GenBank HGNC NONCODE |
Links for papillary thyroid cancer | OMIM COSMIC |